Search Results - "Knable, Michael B"

Refine Results
  1. 1

    Using the NIH Research, Condition and Disease Categorization Database for research advocacy: Schizophrenia research at NIMH as an example by Torrey, E Fuller, Knable, Michael B, Rush, A John, Simmons, Wendy W, Snook, John, Jaffe, D J

    Published in PloS one (19-11-2020)
    “…In 2008 the National Institutes of Health established the Research, Condition and Disease Categorization Database (RCDC) that reports the amount spent by NIH…”
    Get full text
    Journal Article
  2. 2

    Neurochemical markers for schizophrenia, bipolar disorder, and major depression in postmortem brains by Torrey, E. Fuller, Barci, Beata M., Webster, Maree J., Bartko, John J., Meador-Woodruff, James H., Knable, Michael B.

    Published in Biological psychiatry (1969) (01-02-2005)
    “…Previous studies of postmortem neurochemical markers in severe psychiatric disorders have been carried out on different brain collections, making it difficult…”
    Get full text
    Journal Article
  3. 3

    Deficient Hippocampal Neuron Expression of Proteasome, Ubiquitin, and Mitochondrial Genes in Multiple Schizophrenia Cohorts by Altar, C. Anthony, Jurata, Linda W., Charles, Vin, Lemire, Andrew, Liu, Peng, Bukhman, Yury, Young, Theresa A., Bullard, Jeff, Yokoe, Hiroko, Webster, Maree J., Knable, Michael B., Brockman, Jeffrey A.

    Published in Biological psychiatry (1969) (15-07-2005)
    “…Hippocampal dentate granule neurons are altered in schizophrenia, but it is unknown if their gene expressions change in schizophrenia or other psychiatric…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Putative psychosis genes in the prefrontal cortex: combined analysis of gene expression microarrays by Choi, Kwang Ho, Elashoff, Michael, Higgs, Brandon W, Song, Jonathan, Kim, Sanghyeon, Sabunciyan, Sarven, Diglisic, Suad, Yolken, Robert H, Knable, Michael B, Torrey, E Fuller, Webster, Maree J

    Published in BMC psychiatry (07-11-2008)
    “…Recent studies have shown similarities between schizophrenia and bipolar disorder in phenotypes and in genotypes, and those studies have contributed to an…”
    Get full text
    Journal Article
  6. 6

    Dopamine, the prefrontal cortex and schizophrenia by Knable, M B, Weinberger, D R

    Published in Journal of psychopharmacology (Oxford) (01-01-1997)
    “…Dysfunction of the prefrontal cortex (PFC) in schizophrenia has been suspected based on observations from clinical, neuropsychological and neuroimaging…”
    Get more information
    Journal Article
  7. 7

    Multivariate analysis of prefrontal cortical data from the Stanley Foundation Neuropathology Consortium by Knable, Michael B, Torrey, E.Fuller, Webster, Maree J, Bartko, John J

    Published in Brain research bulletin (15-07-2001)
    “…Prefrontal cortical tissue from the Stanley Foundation Neuropathology Consortium, which contains samples from patients with schizophrenia, bipolar disorder,…”
    Get full text
    Journal Article
  8. 8

    Schizophrenia as a developmental disorder of the cerebral cortex by Raedler, Thomas J, Knable, Michael B, Weinberger, Daniel R

    Published in Current opinion in neurobiology (01-02-1998)
    “…The hypothesis that schizophrenia results from a developmental, as opposed to a degenerative, process affecting the cerebral cortex has become popular in…”
    Get full text
    Journal Article
  9. 9
  10. 10

    In Vivo Determination of Muscarinic Acetylcholine Receptor Availability in Schizophrenia by Raedler, Thomas J., Knable, Michael B., Jones, Douglas W., Urbina, Richard A., Gorey, Julia G., Lee, Kan S., Egan, Michael F., Coppola, Richard, Weinberger, Daniel R.

    Published in The American journal of psychiatry (01-01-2003)
    “…OBJECTIVE: Postmortem studies have implicated the central muscarinic acetylcholine system in schizophrenia. However, central muscarinic receptor availability…”
    Get full text
    Journal Article
  11. 11

    Meta-analysis of 12 genomic studies in bipolar disorder by Elashoff, Michael, Higgs, Brandon W, Yolken, Robert H, Knable, Michael B, Weis, Serge, Webster, Maree J, Barci, Beata M, Torrey, E Fuller

    Published in Journal of molecular neuroscience (01-03-2007)
    “…Multiple genome-wide expression studies of bipolar disorder have been published. However, a unified picture of the genomic basis for the disease has not yet…”
    Get full text
    Journal Article
  12. 12

    Reduced Central Serotonin Transporters in Alcoholism by Heinz, Andreas, Ragan, Paul, Jones, Douglas W., Hommer, Dan, Williams, Wendol, Knable, Michael B., Gorey, Julia G., Doty, Linda, Geyer, Christopher, Lee, Kan S., Coppola, Richard, Weinberger, Daniel R., Linnoila, Markku

    Published in The American journal of psychiatry (01-11-1998)
    “…Objective:Dysfunction of monoamine uptake mechanisms has been implicated in the pathogenesis of alcohol dependence. The authors explored whether serotonergic…”
    Get full text
    Journal Article
  13. 13

    Central Muscarinic Acetylcholine Receptor Availability in Patients Treated with Clozapine by RAEDLER, Thomas J, KNABLE, Michael B, JONES, Douglas W, URBINA, Richard A, EGAN, Michael F, WEINBERGER, Daniel R

    Published in Neuropsychopharmacology (01-08-2003)
    “…Clozapine is the prototypical atypical antipsychotic. In vitro, clozapine antagonizes a broad range of receptors, including dopamine, serotonin and muscarinic…”
    Get full text
    Journal Article
  14. 14

    Preliminary experience with an ampakine (CX516) as a single agent for the treatment of schizophrenia: a case series by Marenco, Stefano, Egan, Michael F, Goldberg, Terry E, Knable, Michael B, McClure, Robert K, Winterer, Georg, Weinberger, Daniel R

    Published in Schizophrenia research (01-10-2002)
    “…We used l-(quinoxalin-6-ylcarbonyl)piperidine (CX516) (a modulator of the α-amino-3-hydroxy-5-methyl-4-isoxasole propionic acid (AMPA) receptor) as a sole…”
    Get full text
    Journal Article
  15. 15

    Tourette Syndrome: Prediction of Phenotypic Variation in Monozygotic Twins by Caudate Nucleus D2 Receptor Binding by Wolf, Steven S., Jones, Douglas W., Knable, Michael B., Gorey, Julia G., Lee, Kan Sam, Hyde, Thomas M., Coppola, Richard, Weinberger, Daniel R.

    “…Tourette syndrome, a chronic tic disorder with autosomal dominant inheritance, exhibits considerable phenotypic variability even within monozygotic twin pairs…”
    Get full text
    Journal Article
  16. 16

    In Vivo Olanzapine Occupancy of Muscarinic Acetylcholine Receptors in Patients with Schizophrenia by Raedler, Thomas J, Knable, Michael B, Jones, Douglas W, Lafargue, Todd, Urbina, Richard A, Egan, Michael F, Pickar, David, Weinberger, Daniel R

    Published in Neuropsychopharmacology (New York, N.Y.) (01-07-2000)
    “…Olanzapine is an atypical antipsychotic with potent antimuscarinic properties in vitro (Ki = 2–25 nM). We studied in vivo muscarinic receptor occupancy by…”
    Get full text
    Journal Article
  17. 17

    Secretin for refractory schizophrenia by Sheitman, Brian B., Knable, Michael B., Jarskog, L.Fredrik, Chakos, Miranda, Boyce, Leslie H., Early, John, Lieberman, Jeffrey A.

    Published in Schizophrenia research (01-02-2004)
    “…In preliminary uncontrolled studies, intravenous injection of the gastrointestinal peptide secretin produced improvements in the symptoms of autism. Because of…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Distribution of dopamine D1-D4 receptor subtypes in human dorsal vagal complex by Hyde, Thomas M., Knable, Michael B., Murray, Angela M.

    Published in Synapse (New York, N.Y.) (01-11-1996)
    “…The distribution of D1/D5, D2/D3, D2/D3/D4, and individually, putative D2‐D4 receptors across the dorsal vagal complex of the human medulla was assessed with…”
    Get full text
    Journal Article
  20. 20

    Controlled trial of hydroxychloroquine in schizophrenia by DESTA, Menelik, TADESSE, Azeb, GEBRE, Negussie, BARCI, Beata M, TORREY, E. Fuller, KNABLE, Michael B

    Published in Journal of clinical psychopharmacology (01-10-2002)
    “…Hydroxychloroquine is widely employed for the treatment of rheumatological diseases. A preliminary pilot study suggested that hydroxychloroquine may be a…”
    Get full text
    Journal Article